ZNF143 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.652200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.901800E-01
Normal-vs-Stage2
4.229400E-01
Normal-vs-Stage3
1.787840E-01
Normal-vs-Stage4
8.849600E-01
Stage1-vs-Stage2
6.107600E-01
Stage1-vs-Stage3
2.758400E-01
Stage1-vs-Stage4
1.870770E-01
Stage2-vs-Stage3
1.211210E-01
Stage2-vs-Stage4
2.338800E-01
Stage3-vs-Stage4
1.125990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.613400E-01
Normal-vs-AfricanAmerican
7.752600E-01
Normal-vs-Asian
2.910800E-01
Caucasian-vs-AfricanAmerican
5.228200E-01
Caucasian-vs-Asian
4.182000E-01
AfricanAmerican-vs-Asian
3.828800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.625800E-01
Normal-vs-Female
2.606400E-01
Male-vs-Female
4.337800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.749200E-01
Normal-vs-Age(41-60Yrs)
8.809000E-01
Normal-vs-Age(61-80Yrs)
2.246000E-01
Normal-vs-Age(81-100Yrs)
1.291350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.727640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.059600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.916600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.426650E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.027660E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.420800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.143200E-01
Normal-vs-Daily Drinker
1.635830E-01
Normal-vs-Weekly Drinker
1.648150E-01
Normal-vs-Occasional Drinker
9.465400E-01
Normal-vs-Social Drinker
5.177200E-01
Non Drinker-vs-Daily Drinker
4.328200E-01
Non Drinker-vs-Weekly Drinker
4.763000E-01
Non Drinker-vs-Occasional Drinker
1.703610E-02
Non Drinker-vs-Social Drinker
3.490200E-01
Daily Drinker-vs-Weekly Drinker
9.972600E-01
Daily Drinker-vs-Occasional Drinker
8.642400E-03
Daily Drinker-vs-Social Drinker
1.542180E-01
Weekly Drinker-vs-Occasional Drinker
1.879690E-02
Weekly Drinker-vs-Social Drinker
1.839800E-01
Occasional Drinker-vs-Social Drinker
2.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.713020E-01
Normal-vs-Grade 2
2.319700E-02
Normal-vs-Grade 3
2.343800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.925700E-02
Grade 1-vs-Grade 3
1.818250E-02
Grade 1-vs-Grade 4
1.713020E-01
Grade 2-vs-Grade 3
6.629200E-01
Grade 2-vs-Grade 4
2.319700E-02
Grade 3-vs-Grade 4
2.343800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.461000E-01
Normal-vs-NonDiabetic
2.980600E-01
Diabetic-vs-NonDiabetic
7.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.848400E-01
Normal-vs-NoPancreatitis
3.307000E-01
Pancreatitis-vs-NoPancreatitis
6.136400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.305200E-01
Normal-vs-N1
4.108400E-01
N0-vs-N1
5.997000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.774200E-01
Normal-vs-TP53-NonMutant
3.829600E-01
TP53-Mutant-vs-TP53-NonMutant
2.456100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
